Drugs / Ortho Novum
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00125983 | ? → Jan 2007 | HIV infectious disease, pregnancy disorder | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01200537 Comparator | Oct 2010 → Oct 2011 | female infertility due to oocyte meiotic arrest | Duke University | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ortho-Novum | “Ortho-Novum” NCT01200537 ↗ |
| Known as | ON 1/35 | “The purpose of the study is to examine the interaction between a PI-based regimen containing LPV/r and two forms of contraceptive medications, Ortho Evra and an oral...” NCT00125983 ↗ |
| Route | Oral | “the interaction between a PI-based regimen containing LPV/r and two forms of contraceptive medications, Ortho Evra and an oral contraceptive, Ortho Novum (ON 1/35), in HIV...” NCT00125983 ↗ |